KFF: 82% of Adults Say Prescription Drug Costs are Unreasonable
About three in 10 adults report not taking their medicines as prescribed at some point in the past year because of the cost, according to a survey by KFF.
Affordability of prescription drugs is a key issue for Americans, according to a survey by KFF. This is especially true for those who are taking four or more prescriptions; 37% of these respondents say they have difficulty affording their prescriptions, compared with 18% who currently take three or fewer prescription medications. Those with household incomes of than the $40,000 are more likely to report difficulty affording medications.
Additionally, 31% adults report not taking their medicines as prescribed at some point in the past year because of the cost. This includes 21% who report they have not filled a prescription or took an over-the counter drug instead, and 12% who say they have cut pills in half or skipped a dose because of the cost. (See Figure below.)
Among those surveyed by KFF, 73% support regulations that would address drug prices, including limiting the price of prescription drugs. Among Democrats, 82% support limiting prices; among Republicans, 67% support limiting prices.
Source: KFF
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
March 6th 2025Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 mg dose in August 2024 for the emergency treatment of anaphylaxis in children and adults weighing at least 66 lbs.
Read More
